Evaluate the Safety of BEL-X-HG in Advanced Cancer Patients

Stopped In the light of the on-going COVID-19 pandemic and the resulted difficulty in patient recruitment.

Conditions

• Advanced Solid Tumors

Interventions

• DRUG: BEL-X-HG

Sponsor

Belx Bio-Pharmaceutical (Taiwan) Corporation

Collaborators

• [object Object]